Press Releases

MONMOUTH JUNCTION, N.J., Nov. 4, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its 

VANCOUVER, British Columbia, Nov. 4, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces Dave Lyle, Chief Financial Officer has resigned as an officer, effective November 1st, for pers

NASDAQ: CORV   TSX: CORV VANCOUVER, Nov. 4, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) will hold a Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting in connection

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- Beyond Type 1, a nonprofit organization changing what it means to live with diabetes, and One Drop, a leader in the development of digital therapeutics sol

VANCOUVER, British Columbia, Nov. 4, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company") (CSE:SNN, OTCQB:SNNVF) announces that it continues to work with CannaPharmaRx with respect to the to the sale of Sunniva Medical Inc. ("SMI") to CannaPharmaRx (the "SMI Transaction") and are confident that the SMI Transaction will be completed.

HAYWARD, Calif., Nov. 4, 2019 /PRNewswire/ -- Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS), today announced the upcoming introduction of two new products at the 2019 Association for Molecular Pathology (AMP) Annual Meeting & Expo—a CleanPlex® CFTR Panel for cystic fibrosi

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Children and adolescents (aged 6 to 17 years) living with type 1 diabetes achieved comparable reduction in average blood sugar (HbA1c) and similar risk of low blood sugar events with Toujeo® (insulin glargine injection) 300 Units/mL compared to insulin glargine 100 Units/mL (Gla-100), accordin

PRINCETON, N.J., Nov. 4, 2019 /PRNewswire/ -- healtheo360, a caring social network platform for patients living with chronic, terminal, and rare health conditions has appointed Robert Cecere as its Chief Growth Officer.  Bob, a recognized sales and marketing leader in business development and digital media within healthcare and pharma, will be

LEXINGTON, Mass., Nov. 4, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1, and cancer vaccines provided a corporate update and reported financial results for the third quarter of 2019.

DUBLIN, Nov. 4, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it will present new data from its ARTISTRY clinical development program related to ALKS 4230, an i